Phencyclidine affects memory in a nitric oxide-dependent manner: Working and reference memory

Behavioural Brain Research

Volumn 174, Issue 1, 2006, Pages 49-55

  Wass, Caroline ^a   Archer, Trevor ^b   Pålsson, Erik ^a   Fejgin, Kim ^a   Alexandersson, Åsa ^a   Klamer, Daniel ^a   Engel, Jörgen A ^a   Svensson, Lennart ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

l NAME; Nitric oxide; NMDA receptor antagonist; Phencyclidine; Water maze

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; LEARNING; MALE; MAZE TEST; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SCHIZOPHRENIA; SPATIAL MEMORY; SWIMMING; WORKING MEMORY;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; DRUG INTERACTIONS; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MAZE LEARNING; MEMORY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SPATIAL BEHAVIOR; SWIMMING;

EID: 33748706764     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.07.003     Document Type: Article

References (48)

1. Ahlander M., Misane I., Schott P.A., and Ogren S.O. A behavioral analysis of the spatial learning deficit induced by the NMDA receptor antagonist MK-801 (dizocilpine) in the rat. Neuropsychopharmacology 21 (1999) 414-426
2. Antonova E., Sharma T., Morris R., and Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res 70 (2004) 117-145
3. Apud J.A., and Weinberger D.R. Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs. NeuroRx 3 (2006) 106-116
4. Baba H., Suzuki T., Arai H., and Emson P.C. Expression of nNOS and soluble guanylate cyclase in schizophrenic brain. Neuroreport 15 (2004) 677-680
5. Baldi E., Efoudebe M., Lorenzini C.A., and Bucherelli C. Spatial navigation in the Morris water maze: working and long lasting reference memories. Neurosci Lett 378 (2005) 176-180
6. Bernstein HG, Bogerts B, Keilhoff G. The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 2005.
7. Bouger P.C., and van der Staay F.J. Rats with scopolamine- or MK-801-induced spatial discrimination deficits in the cone field task: animal models for impaired spatial orientation performance. Eur Neuropsychopharmacol 15 (2005) 331-346
8. Butcher S.P., Davis S., and Morris R.G. A dose-related impairment of spatial learning by the NMDA receptor antagonist, 2-amino-5-phosphonovalerate (AP5). Eur Neuropsychopharmacol 1 (1990) 15-20
9. Carlson N.R. Relational learning and amnesia. In: Wakely S.W. (Ed). Physiology of behavior (1998), Allyn and Bacon, Needham Heights, MA 452-476
10. Carlsson M., and Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci 13 (1990) 272-276
11. Chapman P.F., Atkins C.M., Allen M.T., Haley J.E., and Steinmetz J.E. Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport 3 (1992) 567-570
12. Chrapko W.E., Jurasz P., Radomski M.W., Lara N., Archer S.L., and Le Melledo J.M. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol Psychiatry 56 (2004) 129-134
13. Cirillo M.A., and Seidman L.J. Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev 13 (2003) 43-77
14. Deutsch S.I., Rosse R.B., Schwartz B.L., Fay-McCarthy M., Rosenberg P.B., and Fearing K. Methylene blue adjuvant therapy of schizophrenia. Clin Neuropharmacol 20 (1997) 357-363
15. Fejgin K, Pålsson E, Wass C, Engel JA, Svensson L, Klamer D. Local injection of the soluble guanylyl cyclase inhibitor ODQ into the mouse medial prefrontal cortex blocks phencyclidine-induced disruption of prepulse inhibition. Society for Neuroscience, 2005. Abstract Viewer and Itinerary Planner, Washington, DC, USA, 2005.
16. Goldman-Rakic P.S. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 6 (1994) 348-357
17. Goldman-Rakic P.S., and Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 23 (1997) 437-458
18. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 153 (1996) 321-330
19. Hoehn-Saric R., McLeod D.R., and Glowa J.R. The effects of NMDA receptor blockade on the acquisition of a conditioned emotional response. Biol Psychiatry 30 (1991) 170-176
20. Johansson C., Jackson D.M., and Svensson L. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology (Berl) 131 (1997) 167-173
21. Kapur S., and Seeman P. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2) receptors-implications for models of schizophrenia. Mol Psychiatry 7 (2002) 837-844
22. Karatinos J., Rosse R.B., and Deutsch S.I. The nitric oxide pathway: potential implications for treatment of neuropsychiatric disorders. Clin Neuropharmacol 18 (1995) 482-499
23. Karolewicz B., Szebeni K., Stockmeier C.A., Konick L., Overholser J.C., Jurjus G., et al. Low nNOS protein in the locus coeruleus in major depression. J Neurochem 91 (2004) 1057-1066
24. Kesslak J.P., Chuang K.R., and Berchtold N.C. Spatial learning is delayed and brain-derived neurotrophic factor mRNA expression inhibited by administration of MK-801 in rats. Neurosci Lett 353 (2003) 95-98
25. Klamer D., Engel J.A., and Svensson L. The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-l-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. Eur J Pharmacol 503 (2004) 103-107
26. Klamer D., Engel J.A., and Svensson L. The nitric oxide synthase inhibitor, l-NAME, block phencyclidine-induced disruption of prepulse inhibition in mice. Psychopharmacology (Berl) 156 (2001) 182-186
27. Klamer D., Engel J.A., and Svensson L. Phencyclidine-induced behaviour in mice prevented by methylene blue. Pharmacol Toxicol 94 (2004) 65-72
28. Klamer D, Palsson E, Fejgin K, Zhang J, Engel JA, Svensson L. Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition. Psychopharmacology (Berl) 2004.
29. Klamer D., Palsson E., Revesz A., Engel J.A., and Svensson L. Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms. Psychopharmacology (Berl) 176 (2004) 440-450
30. Klamer D., Palsson E., Wass C., Archer T., Engel J.A., and Svensson L. Antagonism of the nitric oxide synthase inhibitor, l-NAME, of the effects of phencyclidine on latent inhibition in taste aversion conditioning. Behav Brain Res 161 (2005) 60-68
31. Klamer D., Zhang J., Engel J.A., and Svensson L. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat. Behav Brain Res 159 (2005) 95-103
32. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51 (1994) 199-214
33. Lu Y.F., Kandel E.R., and Hawkins R.D. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J Neurosci 19 (1999) 10250-10261
34. McGurk S.R., Green M.F., Wirshing W.C., Wirshing D.A., Marder S.R., Mintz J., et al. Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res 68 (2004) 225-233
35. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11 (1984) 47-60
36. Nieto-Escamez F.A., Sanchez-Santed F., and de Bruin J.P. Pretraining or previous non-spatial experience improves spatial learning in the Morris water maze of nucleus basalis lesioned rats. Behav Brain Res 148 (2004) 55-71
37. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., and Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr Res 72 (2004) 29-39
38. O'Dell T.J., Hawkins R.D., Kandel E.R., and Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 88 (1991) 11285-11289
39. Okuyama S., Ogawa S., Nakazato A., and Tomizawa K. Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced delayed cognitive dysfunction in rats. Neurosci Lett 189 (1995) 60-62
40. Palsson E., Klamer D., Wass C., Archer T., Engel J.A., and Svensson L. The effects of phencyclidine on latent inhibition in taste aversion conditioning: differential effects of preexposure and conditioning. Behav Brain Res 157 (2005) 139-146
41. Podhorna J., and Didriksen M. Performance of male C57BL/6J mice and Wistar rats in the water maze following various schedules of phencyclidine treatment. Behav Pharmacol 16 (2005) 25-34
42. Ramirez J., Garnica R., Boll M.C., Montes S., and Rios C. Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study. Schizophr Res 68 (2004) 357-361
43. Reif A., Schmitt A., Fritzen S., Chourbaji S., Bartsch C., Urani A., et al. Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J Neurosci 20 (2004) 885-895
44. Rushe T.M., Woodruff P.W., Murray R.M., and Morris R.G. Episodic memory and learning in patients with chronic schizophrenia. Schizophr Res 35 (1999) 85-96
45. Wass C., Archer T., Pålsson E., Fejgin K., Klamer D., Engel J.A., et al. Effects of phencyclidine on spatial learning and memory: nitric oxide dependent mechanisms. Behav Brain Res 171 (2006) 147-153
46. Wesierska M., Macias-Gonzalez R., and Bures J. Differential effect of ketamine on the reference and working memory versions of the Morris water maze task. Behav Neurosci 104 (1990) 74-83
47. West A.R., Galloway M.P., and Grace A.A. Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse 44 (2002) 227-245
48. Zou L.B., Yamada K., Tanaka T., Kameyama T., and Nabeshima T. Nitric oxide synthase inhibitors impair reference memory formation in a radial arm maze task in rats. Neuropharmacology 37 (1998) 323-330